Progress and Challenges in the Diagnosis of Dementia: A Critical Review
The DOI matches its Crossref record; 153 of the 153 references it cites were found in a registry or an index.
Abstract
Longer life expectancies have led to an increased number of neurodegenerative disease cases globally. Accurate diagnosis of this devastating disorder is of crucial importance but is still feasible only by a brain biopsy after death. An enormous amount of attention and research has been in place over the years toward the better understanding of the mechanisms, as well as the early diagnosis, of neurodegeneration. However, numerous studies have been contradictory from time to time, while new diagnostic methods are constantly developed in a tireless effort to tackle the disease. Nonetheless, there is not yet a conclusive report covering a broader range of techniques for the diagnosis of different types of dementia. In this paper, we critically review current knowledge on the different hypotheses about the pathogenesis of distinct types of dementia, as well as risk factors and current diagnostic approaches in a clinical setting, including neuroimaging, cerebrospinal (CSF), and blood tests. Encouraging research results for the diagnosis and investigation of neurodegenerative disorders are also reported. Particular attention is given to the field of spectroscopy as an emerging tool to detect dementias, follow-up patients, and potentially monitor the patients' response to a therapeutic approach. Spectroscopic techniques, such as infrared and Raman spectroscopy, have facilitated numerous disease-related studies, including neurodegenerative disorders, and are currently undergoing trials for clinical implementation. This review constitutes a comprehensive report with an in-depth focus on promising imaging, molecular biomarker and spectroscopic tests in the field of dementive diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123
Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia
Rascovsky, K., Hodges, J. R., Knopman, D., Mendez, M. F., Kramer, J. H., Neuhaus, J., van Swieten, J. C., Seelaar, H., Dopper, E. G. P., Onyike, C. U., et al. (2011) · Brain · doi:10.1093/brain/awr179 · Cited by 5,221
Diagnosis and management of dementia with Lewy bodies: Third report of the DLB consortium
McKeith, I. G., Dickson, D. W., Lowe, J., Emre, M., O'Brien, J. T., Feldman, H., Cummings, J., Duda, J. E., Lippa, C., Perry, E. K., et al. (2005) · Neurology · doi:10.1212/01.wnl.0000187889.17253.b1 · Cited by 5,069
Frontotemporal lobar degeneration: A consensus on clinical diagnostic criteria
Neary, D., Snowden, J. S., Gustafson, L., Passant, U., Stuss, D., Black, S., Freedman, M., Kertesz, A., Robert, P. H., Albert, M., et al. (1998) · Neurology · doi:10.1212/wnl.51.6.1546 · Cited by 5,047
Román, G. C., Tatemichi, T. K., Erkinjuntti, T., Cummings, J. L., Masdeu, J. C., Garcia, J. H., Amaducci, L., Orgogozo, J.-M., Brun, A., Hofman, A., et al. (1993) · Neurology · doi:10.1212/wnl.43.2.250 · Cited by 4,921
Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium
McKeith, I. G., Boeve, B. F., Dickson, D. W., Halliday, G., Taylor, J.-P., Weintraub, D., Aarsland, D., Galvin, J., Attems, J., Ballard, C. G., et al. (2017) · Neurology · doi:10.1212/wnl.0000000000004058 · Cited by 4,476
Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy
Liu, C.-C., Kanekiyo, T., Xu, H., & Bu, G. (2013) · Nature Reviews Neurology · doi:10.1038/nrneurol.2012.263 · Cited by 3,459
Neuropathological alterations in Alzheimer disease
Serrano-Pozo, A., Frosch, M. P., Masliah, E., & Hyman, B. T. (2011) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006189 · Cited by 3,345
Clinical diagnostic criteria for dementia associated with Parkinson’s disease
Emre, M., Aarsland, D., Brown, R., Burn, D. J., Duyckaerts, C., Mizuno, Y., Broe, G. A., Cummings, J., Dickson, D. W., Gauthier, S., et al. (2007) · Movement Disorders · doi:10.1002/mds.21507 · Cited by 3,027
The projected effect of risk factor reduction on Alzheimer's disease prevalence
Barnes, D. E., & Yaffe, K. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(11)70072-2 · Cited by 2,666
Research works printed but not linked: 5
- Kroner Z., 2009, Altern. Med. Rev., 14, 373
- Casey D. A., 2010, Pharm. Ther., 35, 208
- McKeith I., 2004, Dialogues Clin. Neurosci., 6, 333, 10.31887/dcns.2004.6.3/imckeith · doi:10.31887/dcns.2004.6.3/imckeith
- Rohn T. T., 2014, Int. J. Clin. Exp. Pathol., 7, 3504
- Paraskevaidi M., 2018, under review
Cited by
Kimura, R., Tsujimura, H., Tsuchiya, M., Soga, S., Ota, N., Tanaka, A., & Kim, H. (2020) · Scientific Reports · doi:10.1038/s41598-020-57878-y · Cited by 78
Serum Raman spectroscopy as a diagnostic tool in patients with Huntington's disease
Huefner, A., Kuan, W., Mason, S., Mahajan, S., & Barker, R. A. (2019) · Chemical Science · doi:10.1039/c9sc03711j · Cited by 53
Nabers, A., Hafermann, H., Wiltfang, J., & Gerwert, K. (2019) · Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring · doi:10.1016/j.dadm.2019.01.008 · Cited by 48
Tear-Based Vibrational Spectroscopy Applied to Amyotrophic Lateral Sclerosis
Ami, D., Duse, A., Mereghetti, P., Cozza, F., Ambrosio, F., Ponzini, E., Grandori, R., Lunetta, C., Tavazzi, S., Pezzoli, F., et al. (2021) · Analytical Chemistry · doi:10.1021/acs.analchem.1c02546 · Cited by 44
Ami, D., Mereghetti, P., Foli, A., Tasaki, M., Milani, P., Nuvolone, M., Palladini, G. O., Merlini, G., Lavatelli, F., & Natalello, A. (2019) · Analytical Chemistry · doi:10.1021/acs.analchem.8b05008 · Cited by 38
Machine learning for the life-time risk prediction of Alzheimer’s disease: a systematic review
Rowe, T. W., Katzourou, I. K., Stevenson‐Hoare, J. O., Bracher‐Smith, M., Ivanov, D. K., & Escott‐Price, V. (2021) · Brain Communications · doi:10.1093/braincomms/fcab246 · Cited by 44
Raman Spectroscopy on Brain Disorders: Transition from Fundamental Research to Clinical Applications
Ranasinghe, J. C., Wang, Z., & Huang, S. (2022) · Biosensors · doi:10.3390/bios13010027 · Cited by 36
Extracellular Vesicles in Neurodegenerative Diseases: An Update
Sigdel, S., Swenson, S., & Wang, J. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241713161 · Cited by 31
Frontotemporal EEG as potential biomarker for early MCI: a case–control study
Mitsukura, Y., Sumali, B., Watanabe, H., Ikaga, T., & Nishimura, T. (2022) · BMC Psychiatry · doi:10.1186/s12888-022-03932-0 · Cited by 21
Dementia Care in Canada: Nursing Recommendations
Boscart, V., McNeill, S., & Grinspun, D. R. (2019) · Canadian Journal on Aging / La Revue canadienne du vieillissement · doi:10.1017/s071498081800065x · Cited by 23
Lin, H., Luo, Y., Sun, Q., Deng, K., Chen, Y., Wang, Z., & Huang, P. (2020) · Journal of Biophotonics · doi:10.1002/jbio.201960144 · Cited by 18
Unveiling brain disorders using liquid biopsy and Raman spectroscopy
Ranasinghe, J. C., Wang, Z., & Huang, S. (2024) · Nanoscale · doi:10.1039/d4nr01413h · Cited by 23
Advancements in Neurosurgical Intraoperative Histology
Mohamed, A. A., Sargent, E. C., Williams, C., Karve, Z., Nair, K., & Lucke-Wold, B. P. (2024) · Tomography · doi:10.3390/tomography10050054 · Cited by 16
Non-Invasive Nasal Discharge Fluid and Other Body Fluid Biomarkers in Alzheimer’s Disease
Jung, D. H., Son, G., Kwon, O.-H., Chang, K., & Moon, C. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14081532 · Cited by 14
Ferric–Tannic Nanoparticles Increase Neuronal Cellular Clearance
Phiwchai, I., Chariyarangsitham, W., Phatruengdet, T., & Pilapong, C. (2019) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.9b00345 · Cited by 12
Klamminger, G. G., Frauenknecht, K. B. M., Mittelbronn, M. G. A., & Borgmann, F. B. K. (2022) · Free Neuropathology · doi:10.17879/freeneuropathology-2022-4210 · Cited by 14
Dang, M., Liu, B., Chen, Y., & Zhang, Z. (2026) · Psychoradiology · doi:10.1093/psyrad/kkag007 · Cited by 10
Torres, A. P., Roncero-Parra, C., Borja, A. L., & Mateo-Sotos, J. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-230525 · Cited by 5
Ghamsary, M. S., Ghiasi, M., & Naghavi, S. S. (2024) · Physical Chemistry Chemical Physics · doi:10.1039/d3cp05687b · Cited by 3
Huang, Y., Li, Z., Liu, F., Li, B., Mao, C., Dong, L., Chu, S., Jin, W., Wang, J., & Gao, J. (2025) · Journal of Alzheimer s Disease · doi:10.1177/13872877251360331 · Cited by 6
Uraizee, I., Varma, V. K., Sreedhar, H., Gambacorta, F. V., Nazeer, S. S., Husain, A. N., & Walsh, M. J. (2018) · Transplantation · doi:10.1097/tp.0000000000002465 · Cited by 3
Bharanidharan, N., & Rajaguru, H. (2021) · World Congress on Medical Physics and Biomedical Engineering, September 7 - 12, 2009, Munich, Germany · doi:10.1007/978-3-030-62045-5_13 · Cited by 3
Bharanidharan, N., Chakravarthy, S. R. S., & Rajaguru, H. (2022) · World Congress on Medical Physics and Biomedical Engineering, September 7 - 12, 2009, Munich, Germany · doi:10.1007/978-3-030-90724-2_6 · Cited by 3
Din, F. U., Giri, N., Shetty, N. K., Hilton, T., Shafiabady, N., & Tully, P. J. (2025) · BioMedInformatics · doi:10.3390/biomedinformatics5030049 · Cited by 2
Chemical Approaches for Array Based Detection of Amyloids
Simon, P. M., Xu, Y., & Kaur, A. (2025) · Advanced Sensor Research · doi:10.1002/adsr.202500108 · Cited by 1
Bharanidharan, N., & Rajaguru, H. (2022) · World Congress on Medical Physics and Biomedical Engineering, September 7 - 12, 2009, Munich, Germany · doi:10.1007/978-3-030-93564-1_14 · Cited by 1
Minami, T., Shirakawa, J., Kameda, A., Suzuki, Y., Watanabe, K., Yamada, T., Hiiragi, H., Takeda, S., Takahashi, M., & Terauchi, Y. (2020) · Diabetology International · doi:10.1007/s13340-020-00452-8
Bharanidharan, N., Chakravarthy, S. R. S., & Rajaguru, H. (2021) · Advances in intelligent systems and computing · doi:10.1007/978-981-16-4369-9_44
Cognitive function and Alzheimer: Future direction to prevent the risk
Ramar, K., Revathi, A. R., Saravanan, T. R., Manju, A., & Gayathri, A. (2022) · AIP conference proceedings · doi:10.1063/5.0101014
Malagueta, G. L. L. (2022) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Zhang, H., Huang, J., & Zhou, F. J. (2026) · Journal of Family Medicine and Primary Care · doi:10.4103/jfmpc.jfmpc_4_24
Lakbiri, A., Jilbab, A., & Hammouch, A. (2026) · International Symposium on Signal, Image, Video and Communications (ISIVC) · doi:10.1109/isivc69944.2026.11574061
Metadata
- Authors
- Paraskevaidi, M., Martin-Hirsch, P. L., & Martin, F. L.
- Affiliations
- University of Lancashire (GB)
- Department of Obstetrics and Gynaecology, Central Lancashire Teaching Hospitals NHS Foundation Trust, Preston PR2 9HT, United Kingdom
- Corresponding author
- Paraskevaidi, Maria
- Martin, Francis L.
- Venue
- ACS Chemical Neuroscience
- Publisher
- American Chemical Society (ACS)
- Published
- 2018-02-01
- Volume
- 9
- Issue
- 3
- Pages
- 446-461
- ISSN
- 1948-7193 (ISSN-L)
- OpenAlex
- W2786360376
- Cited by
- 31
- References
- 153
- Citations by year
- 2026: 3 · 2025: 3 · 2024: 3 · 2023: 2 · 2022: 7 · 2021: 4 · 2020: 3 · 2019: 5 · 2018: 1
- FWCI
- 0.50
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- ACS Chemical Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- CLOK (University of Central Lancashire) (acceptedVersion)
- Funders
- Rosemere Cancer Foundation
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biophysics › Spectroscopy Techniques in Biomedical and Chemical Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Keywords
- dementia diagnosis, neurodegenerative diseases, dementia pathogenesis, risk factors, neuroimaging, cerebrospinal fluid biomarkers, blood biomarkers, infrared spectroscopy, Raman spectroscopy, disease surveillance
- MeSH terms
- Alzheimer Disease, Animals, Dementia, Humans, Risk, Spectrum Analysis, Raman, Biomarkers, Neuroimaging
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.